Page last updated: 2024-08-22

fluorescein-5-isothiocyanate and Thyroid Carcinoma, Anaplastic

fluorescein-5-isothiocyanate has been researched along with Thyroid Carcinoma, Anaplastic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, JC; Biswas, R; Chung, PS; Lee, SH; Moon, JH1

Other Studies

1 other study(ies) available for fluorescein-5-isothiocyanate and Thyroid Carcinoma, Anaplastic

ArticleYear
Carboplatin synergistically triggers the efficacy of photodynamic therapy via caspase 3-, 8-, and 12-dependent pathways in human anaplastic thyroid cancer cells.
    Lasers in medical science, 2014, Volume: 29, Issue:3

    Topics: Annexin A5; Apoptosis; Blotting, Western; Carboplatin; Caspase 12; Caspase 3; Caspase 8; Caspases; Cell Cycle; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Cytochromes c; Endoplasmic Reticulum Stress; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; Membrane Potential, Mitochondrial; Mitochondrial Proteins; Photochemotherapy; Propidium; Reactive Oxygen Species; Signal Transduction; Thyroid Carcinoma, Anaplastic

2014